| Monitoring the Safety of Medicines Used Off-Label. | |
| | |
MedLine Citation:
|
PMID: 22472983 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Off-label use of medicines is common. Because many off-label uses have not been carefully studied, it is important that postmarketing drug safety systems be able to identify, assess, and monitor adverse events that occur in the off-label setting. The full range of postmarketing surveillance and analysis tools can be utilized to study the adverse effects of medicines used off-label. |
| | |
Authors:
|
G J Dal Pan |
Related Documents
:
|
8330393 - Can medical decisions be standardized? should they be? 18855623 - Enkephalinase inhibitors: potential agents for the management of pain. 12457473 - A survey of attitudes to abortion law in northern ireland amongst obstetricians, gynaec... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-04 |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: - ISSN: 1532-6535 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Office of Surveillance and Epidemiology, US Food and Drug Administration, Silver Spring, Maryland, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Shape-controlled tunable homochromatic luminescence and inner photoelectric effect of hexagonal Na(1...
Next Document: The Use of Observational Health-Care Data to Identify and Report on Off-Label Use of Biopharmaceutic...